Preview Workflow

The CIM Courses system will be down temporarily undergoing routine maintenance.

Viewing: PUBH 6374 : Pharmaceutical Policy

Last approved: Mon, 11 Apr 2016 09:02:31 GMT

Last edit: Fri, 25 Mar 2016 15:09:15 GMT

Catalog Pages referencing this course
Milken Institute School of Public Health
Public Health (PUBH)
Pharmaceutical Policy
Pharmaceutical Policy
Course Type
Default Grading Method
Letter Grade

PUBH 6315

Frequency of Offering

Term(s) Offered

Are there Course Equivalents?
Fee Type


Legal and regulatory frameworks related to the demand for and supply / quality of pharmaceutical products. Policies specific to drug development, pricing, reimbursement, use, dissemination of information, and post-marketing surveillance.
By the end of this course students will have an understanding of: 1. Basic concepts in pharmaceutical policy and the nature of the pharmaceuticals market. 2. The stages of drug development, and the lifecycle of a medicine 3. The history, ethos, scope, and current challenges surrounding the regulation of medicines. 4. The fundamentals of pharmaceutical intellectual property protection and the implications of this for pharmaceutical R&D, regulation, financing, pricing and access to medicines 5. State and federal programs and private sector approaches to prescription drug financing and coverage. 6. Issues in advertising and promotion of prescription and over-the-counter drugs, and of industry-provider relationships 7. An overview of CER and HTA and their application to pharmaceutical policy decision-making 8. Key differences between pharmaceutical policies in the US and other major industrialized nations. 9. Challenges and opportunities in the provision of access to medicines around the world. 10. An overview of key challenges in pharmaceutical policy. 11. How to critically appraise pharmaceutical policies and develop policy options for improving these.

Course Attribute

ebrunori (Mon, 12 Jan 2015 16:05:27 GMT): update syllabus
Key: 7852